The pathological diagnosis was anaplastic oligodendroglioma (WHO grade III), with IDH1:p.R132H, PIK3R1:p.G376R, CIC:p.N205S, and FUBP1:p.Y505Gfs*16 mutations confirmed as driver genes in tumor tissue. This evidence concerns the gene FUBP1 and anaplastic oligodendroglioma.